Newsroom

Newsroom

Motor Fuel Group logo

Press Release

July 17, 2015
Clayton, Dubilier & Rice, LLC (“CD&R”) and Motor Fuel Group (“MFG” or the "Company") announced today that funds managed by CD&R, partnering with the management of the Company, have completed the previously-announced acquisition of Motor...
Vets First Choice logo

Press Release

July 2, 2015
Vets First Choice, the leading provider of veterinary pharmacy, prescription management and compliance marketing services, announced today a significant investment by Clayton, Dubilier & Rice (CD&R) and existing shareholders to accelerate...

Perspectives

June 23, 2015
A candid, thought provoking discussion on the challenges and rewards of finding a lasting work-life balance, despite demanding professional careers.
Univar logo

Press Release

June 17, 2015
Univar Inc., a global chemical distributor and provider of value-added services, announced today the pricing of its initial public offering of 35,000,000 shares of common stock at a price to the public of $22.00 per share. Univar Inc. will sell 20,...
Motor Fuel Group logo

Press Release

June 8, 2015
Clayton, Dubilier & Rice, LLC (“CD&R”) and Patron Capital Partners (“Patron”) today announce that funds managed by CD&R will be partnering with the management of Motor Fuel Group (“MFG” or the "Company") to acquire the Company from...
Healogics logo

Press Release

May 21, 2015
Clayton, Dubilier & Rice today announced an agreement under which CD&R-managed funds will acquire Healogics Holding Corp., the largest advanced wound care services provider in the U.S., from Metalmark Capital and Scale Venture Partners. The...
MAUSER logo

Press Release

May 12, 2015
Clayton, Dubilier & Rice today announced an agreement under which CD&R-managed funds will acquire Mauser Group, one of the world’s leading industrial packaging companies. The transaction is valued at approximately €1.2 billion. Additional...
BCA logo

Press Release

March 26, 2015
Clayton, Dubilier & Rice today announced the sale of BCA, Europe’s largest used vehicle marketplace, to Haversham Holdings, the publicly listed investment vehicle, in a transaction valued at approximately £1.2 billion. Shareholders of BCA, which...
Photo of Jillian Griffiths

Press Release

March 9, 2015
Clayton, Dubilier & Rice (“CD&R”) today announced the appointment of Jillian Griffiths as Chief Operating Officer, effective March 4. Ms. Griffiths is a 22-year veteran and former partner of PricewaterhouseCoopers (“PwC”). She will assume...
Photo of Ravi Sachdev

Press Release

March 6, 2015
Clayton, Dubilier & Rice (“CD&R”) today announced that Ravi Sachdev, former Managing Director for Healthcare Coverage and Co-Head of Healthcare Services at J.P. Morgan, will join the Firm as a Partner. Mr. Sachdev brings to CD&R...
Vera Whole Health Logo.

Press Release

February 17, 2022
Vera Whole Health, Inc. ("Vera") announced today that it has successfully completed its previously announced acquisition of Castlight Health, Inc. ("Castlight") at a price of $2.05 per share, net to the seller, in cash, without interest and subject...
Andrea Peiro

Press Release

February 9, 2022
Clayton, Dubilier & Rice announced the appointment of Andrea Peiro, an experienced technology professional and successful entrepreneur, as an Operating Principal. In his new role, Mr. Peiro will be engaged in evaluating investments and help...
Hand holding a seedling.

Perspectives

February 7, 2022
The conversation about private equity and environmental, social and corporate governance (ESG) has been largely around reporting guidelines and metrics. We believe private equity is well-positioned to drive and scale ESG best practices. The...
Anand Shah, M.D.

Press Release

February 3, 2022
Clayton, Dubilier & Rice today announced Anand Shah, M.D., former U.S. Food and Drug Administration (“FDA”) Deputy Commissioner for Medical and Scientific Affairs, as an Operating Advisor to CD&R funds. Dr. Shah will work with CD&R’s...
Vera Whole Health and Castlight Health logos

Press Release

January 5, 2022
Castlight Health, Inc. (“Castlight”) (NYSE: CSLT), a leading healthcare data and navigation company, and Vera Whole Health, Inc. (“Vera”), a pioneer in advanced primary care, today jointly announced an agreement under which the companies will...
Jon Selib Headshot

Press Release

December 21, 2021
Clayton, Dubilier & Rice today announced the appointment of Jon Selib, former Senior Vice President of Global Policy & Public Affairs at Pfizer, as Managing Director and Global External Affairs Leader. In his new role, which will take effect...
Belron logo

Press Release

December 17, 2021
Clayton, Dubilier & Rice Fund X today announced the sale of its investment in Belron, a worldwide leader in vehicle glass repair and replacement. The two-part transaction included the sale of approximately 39% of CD&R Fund X’s stake to funds...
Gordon Riske

Press Release

December 13, 2021
Clayton, Dubilier & Rice announced today that Gordon Riske will be engaged as an Operating Advisor to CD&R funds effective January 1, 2022 after he steps down as Chief Executive Officer of KION GROUP AG, a global provider of materials...

Events

December 7, 2021
CD&R Chairman Don Gogel joined Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC), in a London Business School fireside chat titled, “In conversation with Don Gogel: private capital in...
Screen shot from video
Play Video

Events

December 7, 2021
CD&R Chairman Don Gogel discusses trends and opportunities in private capital with Professor Florin Vasvari, Academic Director of the Institute of Entrepreneurship and Private Capital (IEPC) at London Business School. The video below...
Certain persons quoted in certain news items are advisors to CD&R’s funds or executives, employees, directors or persons serving in similar capacities in CD&R’s funds’ portfolio companies, or other persons or organizations who have or may in the future have business or other relationships with CD&R or its funds. Such relationships and any compensation associated with them create a conflict of interest, as the relationship and/or the compensation incentivizes such person to endorse CD&R or its funds.